Fulgent Genetics
FLGT
$20.10
Share price
0.35%
Change (1 day)
-30.93%
Change (1 year)
Fulgent Genetics (FLGT) - Cash on Hand
Cash on Hand as of December 2023 : $0.42 B
According to Fulgent Genetics
's latest financial reports the company has $0.42 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Fulgent Genetics - Cash on Hand chart (from 2015 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.42 B | -19.4% |
| 2022-12-31 | $0.52 B | 16.81% |
| 2021-12-31 | $0.45 B | 50.48% |
| 2020-12-31 | $0.29 B | 958.99% |
| 2019-12-31 | $28.26 M | -8.91% |
| 2018-12-31 | $31.03 M | 17.18% |
| 2017-12-31 | $26.48 M | 26.91% |
| 2016-12-31 | $20.86 M | 4167.48% |
| 2015-12-31 | $0.48 M | 184.3% |
| 2014-12-31 | $0.17 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 PAVmed
PAVM | $26.4 M | -93.77% | 🇺🇸 USA |
 Philips PHG | $2.06 B | 387.95% | 🇳🇱 Netherlands |